MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a CTDMO (contract testing, development, and manufacturing organization) will offer integrated services for all critical stages of mRNA development, manufacturing, and commercialization, including products and testing. The company opened two new GMP-grade mRNA drug substance manufacturing sites in Darmstadt and Hamburg, Germany. The new sites are part of the company’s ongoing €1 billion investmen...